B. Xu

4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

Fátima Cardoso, Elżbieta Senkus, A. Costa et al. · Annals of Oncology · 2018 · 1.1K citations · Full text

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Sibylle Loibl, Fabrice André, Thomas Bachelot et al. · Annals of Oncology · 2023 · 684 citations · Full text

Surgical Oncology, Breast Oncology, Early Breast Cancer +7

Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023

Giuseppe Curigliano, Harold J. Burstein, Michael Gnant et al. · Annals of Oncology · 2023 · 189 citations · Full text

A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial

Gabriel N. Hortobágyi, Joohyuk Sohn, F. Melo Cruz et al. · Annals of Oncology · 2024 · 70 citations · Full text

Efficacy of utidelone plus capecitabine versus capecitabine for heavily pretreated, anthracycline- and taxane-refractory metastatic breast cancer: final analysis of overall survival in a phase III randomised controlled trial

B. Xu, Tao Sun, Q. Zhang et al. · Annals of Oncology · 2020 · 43 citations

Breast Oncology, Oncology, Capecitabine Versus Capecitabine +7